Literature DB >> 30063252

Risk factors and seroprevalence of hepatitis E evaluated in frozen-serum samples (2002-2003) of pregnant women compared with female blood donors in a Southern region of Brazil.

S Hardtke1,2, R Rocco3, J Ogata3, S Braga3, M Barbosa3, A Wranke1, E Doi2, D da Cunha4, E Maluf3, H Wedemeyer1,2, D Muzzillo3.   

Abstract

Hepatitis E has always been related to morbidity in pregnant women. Its epidemiology is not well understood in Brazil. Therefore, we tested sera from 209 pregnant women and 199 female blood donors, collected at a single center in Curitiba, Brazil. The Wantai assay was used for testing the anti-hepatitis E virus (anti-HEV), immunoglobulin G (IgG), and an in-house polymerase chain reaction process for testing HEV RNA. Anti-HEV was detected in 22.5% of the total group, 19% in the pregnant women group, and 26% in the blood donor group (P = 0.11), a much higher prevalence when compared with other studies in Brazil. Demographical analysis showed that 92.4% were born in the South Region of Brazil, 4.9% in the Southeast, and 2.7% were distributed over other regions of the country. With respect to their origin, 99% were from the South, 0.7% from the Southeast, and 0.2% from the Central-West regions. Income, education, race, number of pregnancies, and abortion did differ significantly when comparing both the groups (P < 0.001). Age >30 (P = 0.012) and the number (>3) of pregnancies (P = 0.008) were related to anti-HEV positivity. All anti-HEV IgG-positive females were HEV RNA negative. In conclusion, HEV positivity was found in one out of five young women, which showed an urgent need for further epidemiological studies in Brazil.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Brazil; Hepatitis E; Hepatitis E virus; pregnancy

Mesh:

Substances:

Year:  2018        PMID: 30063252     DOI: 10.1002/jmv.25274

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Seroprevalence of hepatitis E virus infection in the Americas: Estimates from a systematic review and meta-analysis.

Authors:  Nathalie Verónica Fernández Villalobos; Barbora Kessel; Isti Rodiah; Jördis Jennifer Ott; Berit Lange; Gérard Krause
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

2.  Hepatitis E virus infection in pregnant women, Argentina.

Authors:  Gabriela Tissera; María Cecilia Lardizabal; Sofía Belén Torres; Anabella Clara Fantilli; Maribel G Martínez Wassaf; Fernando Venezuela; Raúl Capra; Domingo C Balderramo; Claudia Travella; Viviana E Ré; María Belén Pisano
Journal:  BMC Infect Dis       Date:  2020-05-24       Impact factor: 3.090

3.  Seroprevalence of hepatitis E virus in risk populations and blood donors in a referral hospital in the south of Brazil.

Authors:  Marisa Boff Costa; Michele Soares Gomes Gouvêa; Samira Chuffi; Gustavo Hirata Dellavia; Felipe Ornel; Lísia Von Diemen; Félix Kessler; João Renato Rebello Pinho; Mário Reis Álvares-da-Silva
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.